Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $10.7B | SEC | |
| Buy | $50M | SEC | |
| Buy | $24.8B | SEC | |
| Buy | $857.5M | SEC | |
| Buy | $16.7T | SEC | |
| Buy | $687.5M | SEC | |
| Buy | $224.1M | SEC | |
| Buy | $1.8B | SEC | |
| Buy | $1.8B | SEC | |
| Buy | $999.4B | SEC | |
| Buy | $4.9B | SEC | |
| Buy | $55M | SEC | |
| Buy | $31.7B | SEC | |
| Buy | $10B | SEC | |
| Buy | $175.6T | SEC | |
| Buy | $1.3B | SEC | |
| Buy | $39.5B | SEC | |
| Buy | $7.3B | SEC | |
| Buy | $3.2B | SEC | |
| Buy | $4B | SEC | |
| Buy | $30.8B | SEC | |
| Buy | $253.3B | SEC | |
| Buy | $7.3B | SEC |